Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High sensitivity C-reactive protein in clinical practice.

José L Torres1, Paul M Ridker

  • 1Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.

The American Heart Hospital Journal
|March 24, 2005
PubMed
Summary

High sensitivity C-reactive protein (hs-CRP) effectively predicts cardiovascular disease risk, even in patients with low LDL cholesterol. hs-CRP should be used with lipid evaluation for comprehensive risk assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of carotid web angioarchitecture in stratification of stroke risk.

Journal of neurointerventional surgery·2025
Same author

Use of Carotid Web Angioarchitecture for Stroke Risk Assessment.

World neurosurgery·2023
Same author

Neuroprotective association of preoperative renin-angiotensin system blocking agents use in patients undergoing carotid interventions.

Vascular·2022
Same author

Systemic Inflammatory Response Syndrome is Associated with Hematoma Expansion in Intracerebral Hemorrhage.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2021
Same author

Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2020
Same author

The production of national defense and the macroeconomy.

PloS one·2020

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiology

Background:

  • Atherosclerosis diagnosis in patients with low LDL cholesterol necessitates novel risk prediction markers.
  • Inflammation markers, including cytokines, cell adhesion molecules, and acute phase reactants, are under investigation.
  • High sensitivity C-reactive protein (hs-CRP) is an innate immune response protein with potential prognostic value.

Purpose of the Study:

  • To evaluate the utility of hs-CRP in predicting cardiovascular risk across diverse patient populations.
  • To determine the role of hs-CRP in conjunction with traditional risk factors like LDL cholesterol and metabolic syndrome.

Main Methods:

  • Utilized high-sensitivity assays to measure hs-CRP levels.
  • Correlated hs-CRP levels with cardiovascular risk stratification in apparently healthy individuals.

Related Experiment Videos

  • Assessed hs-CRP performance across varying LDL cholesterol, Framingham Risk Score, and metabolic syndrome categories.

    • Main Results:

    • hs-CRP levels predict future cardiovascular risk independently of LDL cholesterol and Framingham Risk Score.
    • hs-CRP levels of <1 mg/L, 1-3 mg/L, and >3 mg/L correspond to low, moderate, and high cardiovascular risk, respectively.
    • hs-CRP demonstrates prognostic value across all levels of metabolic syndrome.

    Conclusions:

    • hs-CRP is a valuable marker for global cardiovascular risk assessment, complementing lipid evaluations.
    • Integrating hs-CRP into clinical practice can enhance risk stratification and guide preventive interventions.
    • Improved cardiovascular risk knowledge may improve adherence to lifestyle and pharmacologic treatments for preventing cardiovascular events.